Public Policy Updates

Check insights and updates from APIC!

CMS Suppresses NHSN HAI Measures Due to COVID Pandemic
02/11/2022
CMS Suppresses NHSN HAI Measures Due to COVID Pandemic

1/13/22 — In the FY 2022 Hospital Inpatient Prospective Payment System (IPPS) final rule, CMS implemented a “Measure Suppression Policy.” Under this policy, CMS will not use certain measures (including NHSN HAI measures) from the Q3 and Q4 2020 reporting periods for performance scoring in the Hospital-Acquired Condition (HAC) Reduction Program and the Hospital Value-Based … Continued

Read More
CMS Updates Nursing Home Visitation FAQs
02/11/2022
CMS Updates Nursing Home Visitation FAQs

1/11/22 — CMS has updated its “Nursing Home Visitation FAQs” document to provide additional clarification on its revised guidance issued in November 2021. The key message is that visitation must be permitted at all times with very limited and rare exceptions, in accordance with residents’ rights. Nursing homes should enable visitation following these three key points: • Adhere to … Continued

Read More
NIOSH Rescinds Approvals for ALG Health Respirators
02/11/2022
NIOSH Rescinds Approvals for ALG Health Respirators

1/11/22 — NIOSH has honored a request by ALG Health to voluntarily rescind ALL NIOSH respirator approvals issued to ALG Health. As of January 6, 2022, any respirator marked with a NIOSH approval label indicating any of the following approval numbers is no longer NIOSH-approved. TC-84A-9259, TC-84A -9262, TC-84A-9270, TC-84A-9271, TC-84A-9273, TC-84A-9274, TC-84A-9275, TC-84A-9280, TC-84A-9281, TC-84A-9282, TC- 84A-9288, … Continued

Read More
FDA/CDC Shorten Booster Interval for Moderna COVID-19 Vaccine
02/11/2022
FDA/CDC Shorten Booster Interval for Moderna COVID-19 Vaccine

1/7/22 — The FDA amended the EUA for the Moderna COVID-19 vaccine to shorten the time between the completion of a primary series of the vaccine and a booster dose to at least five months for individuals 18 years of age and older.The CDC followed suit by updating its recommendation for getting the a Moderna … Continued

Read More
FDA Stop Use Order for LuSys Lab COVID-19 Test
02/11/2022
FDA Stop Use Order for LuSys Lab COVID-19 Test

1/11/22 — The FDA is warning people to stop using the LuSys Laboratories COVID-19 Antigen Test (Nasal/Saliva) and the LuSys Laboratories COVID-19 IgG/IgM Antibody Test. The performance of these tests has not been adequately established and the FDA believes there is likely a high risk of false results when using these tests. Neither test has been authorized, cleared, … Continued

Read More
Latest School Guidance from CDC
01/06/2022
Latest School Guidance from CDC

1/6/22 — CDC has released updated guidance for schools regarding COVID-19. Click on the links below to learn more. Guidance for COVID-19 Prevention in K-12 Schools – CDC update 1/6/22 Overview of COVID-19 Isolation for Schools – CDC update 1/6/22 Overview of COVID-19 Quarantine for Schools – CDC update 1/6/22 Responding to COVID-19 Cases in K-12 Schools: Resources … Continued

Read More
CDC Updates Isolation Recommendations for the Public
01/06/2022
CDC Updates Isolation Recommendations for the Public

1/4/22 — The CDC has updated isolation and quarantine recommendations for the public. These recommendations do not apply to healthcare personnel. New recommendations state the people with COVID-19 should isolate for 5 days, and if they are asymptomatic or their symptoms are resolving, follow that by 5 days of wearing a mask when around others. … Continued

Read More
Covidien Recalls Ventilator Due to Manufacturing Error
01/06/2022
Covidien Recalls Ventilator Due to Manufacturing Error

1/3/22 — Covidien, LP is recalling its Puritan Bennett 980 Series Ventilator due to a capacitor manufacturing assembly error that may cause the ventilator to become inoperable or stop working as intended. Read the FDA recall notice.

Read More
FDA and CDC Expand Pfizer Vaccine Recommendations
01/06/2022
FDA and CDC Expand Pfizer Vaccine Recommendations

1/3/22 — The FDA amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine. The revised EUA: Expands the use of a single booster dose to include use in individuals age 12 through 15 Shorten the time between the completion of the primary vaccination series and a booster dose to at least five months … Continued

Read More